News

Energizer rolls out Advanced Lithium batteries

BY Doug Desjardins

ST. LOUIS Energizer has introduced a new line of Advanced Lithium batteries that can power portable devices up to 20 hours longer than regular batteries.

The new AA and AAA batteries are designed for high-drain devices like MP3 players, digital cameras and handheld game consoles and last four times longer than other batteries in their class.

“Advanced Lithium is our latest addition to the performance battery segment and we expect it to appeal to active gamers, music lovers and others who are interested in enjoying the benefits of our industry-leading lithium technology,” said Besty Laakko, director of battery marketing for Energizer. The batteries come in four-packs that retail for $7.99.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

News

Court rules against Watson in Naprelan case

BY Drew Buono

CORONA, Calif. The United States District Court for the Southern District of Florida ruled that Watson Pharmaceuticals’ naproxen sodium extended-release tablets, a generic version of the pain medication Naprelan, infringes the brand drug manufacturer’s patent, Watson announced Wednesday.

Elan initially brought the suit in October 1998 after Andrx filed an application for a generic version of the drug. In March 2002, the District Court ruled that Elan’s ‘320 patent was invalid. Watson acquired Andrx in November 2006.

In May 2004, the United States Court of Appeals for the Federal Circuit reversed the District Court’s finding of invalidity and remanded the case for further proceedings. In January 2005, Elan filed a related case against Andrx in the United States District Court for the Southern District of Florida alleging that Andrx’s generic drug infringes the patent and is seeking damages for willful infringement. In late 2005, the parties completed briefing the District Court on the validity of the patent and whether Andrx’s product infringes it, and the matter has been under submission to the District Court since then.

Watson said it intends to appeal the ruling.

Watson’s naproxen sodium tablets had sales of $4 million over the year ending June 30, according to IMS data.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

News

Medicare officials predict lower 2009 Part D costs than expected

BY Alaric DeArment

WASHINGTON Monthly premiums for Medicare’s Part D prescription drug program next year will be lower than expected, Medicare officials announced Thursday.

Based on bids submitted by Part D plans, the Centers for Medicare & Medicaid Services estimated that the average monthly premium that recipients will pay for standard Part D coverage will be $28 – lower than the $44.12 predicted in 2003.

At the same time, it is $3 more than the premium for this year, mainly because of rising drug costs and higher plan estimates for catastrophic coverage and the phase-out of a CMS demonstration project.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES